What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Dementia
Rik Ossenkoppele mainly focuses on Alzheimer's disease, Dementia, Positron emission tomography, Pathology and Neuroscience.
His Alzheimer's disease study incorporates themes from Frontotemporal dementia, Psychiatry, Cognition, Atrophy and Amyloid.
His Dementia research is multidisciplinary, incorporating elements of Meta-analysis, Apolipoprotein E, Neurology and Neurodegeneration.
Neurodegeneration is a subfield of Disease that Rik Ossenkoppele explores.
In his study, Fluorodeoxyglucose and Cerebral cortex is strongly linked to Pittsburgh compound B, which falls under the umbrella field of Positron emission tomography.
Neuroscience is represented through his Human brain and Posterior cingulate research.
His most cited work include:
- Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. (731 citations)
- PET Imaging of Tau Deposition in the Aging Human Brain (534 citations)
- PET Imaging of Tau Deposition in the Aging Human Brain (534 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Disease, Dementia, Neuroscience, Internal medicine and Pathology.
His Disease research incorporates themes from Clinical psychology, Cognition and Atrophy.
His Dementia research is multidisciplinary, incorporating perspectives in Alzheimer's disease, Positron emission tomography, Neurology and Cognitive impairment.
His study looks at the relationship between Alzheimer's disease and fields such as Frontotemporal dementia, as well as how they intersect with chemical problems.
Many of his research projects under Neuroscience are closely connected to Covariance with Covariance, tying the diverse disciplines of science together.
He interconnects Endocrinology, Oncology and Cardiology in the investigation of issues within Internal medicine.
He most often published in these fields:
- Disease (70.37%)
- Dementia (52.84%)
- Neuroscience (45.93%)
What were the highlights of his more recent work (between 2020-2021)?
- Disease (70.37%)
- Dementia (52.84%)
- Biomarker (19.75%)
In recent papers he was focusing on the following fields of study:
Rik Ossenkoppele mainly investigates Disease, Dementia, Biomarker, Internal medicine and Oncology.
His work deals with themes such as Neuroimaging and Cognition, which intersect with Disease.
His Dementia research includes themes of Positron emission tomography, Neurology, Cognitive impairment and Cohort.
His Positron emission tomography research is within the category of Neuroscience.
His Biomarker study combines topics in areas such as Phospho tau, Clinical validity, Data science and Data extraction.
Rik Ossenkoppele is interested in Apolipoprotein E, which is a field of Internal medicine.
Between 2020 and 2021, his most popular works were:
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. (7 citations)
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. (7 citations)
- Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. (6 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Disease
His scientific interests lie mostly in Biomarker, Disease, Clinical validity, Context and Early detection.
The various areas that Rik Ossenkoppele examines in his Biomarker study include Phospho tau, Tau pathology, Oncology and Data extraction.
Amyloid and Dementia are among the areas of Disease where the researcher is concentrating his efforts.
His Amyloid study results in a more complete grasp of Pathology.
He has researched Dementia in several fields, including Positron emission tomography, Neurology, Molecular pathology and Blood biomarkers.
His research integrates issues of Discriminative model and Intensive care medicine in his study of Early detection.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
